Risk factors and outcomes of prolonged recovery from delayed graft function after deceased kidney transplantation

Huanxi Zhang,Qian Fu,Jinqi Liu,Jun Li,Ronghai Deng,Chenglin Wu,Weijian Nie,Xutao Chen,Longshan Liu,Changxi Wang
DOI: https://doi.org/10.1080/0886022x.2020.1803084
IF: 3.222
2020-08-12
Renal Failure
Abstract:We aimed to evaluate the effect of prolonged recovery from DGF on outcomes, using a new definition of DGF recovery time, among deceased donor kidney transplant recipients with DGF, and to examine the risk factors for prolonged recovery. From 2007 to 2016, 91 deceased donor kidney transplant recipients with DGF were retrospectively analyzed. DGF recovery time was defined as the time from transplantation to achieve a stable estimated glomerular filtration rate (eGFR). Recipients with a DGF recovery time greater than or equal to the median were assigned to the prolonged recovery group, while the others were assigned to the rapid recovery group. The median DGF recovery time was 27 days. Donor terminal eGFR was significantly lower in the prolonged recovery group ( n = 46) compared with the rapid recovery group ( n = 45) (median 24.9 vs. 65.4 ml/min/1.73m 2 , p = 0.004). The eGFR at 1 year post-transplant in the prolonged recovery group was significantly lower than that in the rapid recovery group (50.6 ± 20.0 vs. 63.5 ± 21.4 ml/min/1.73m 2 , p = 0.005). The risk of adverse outcomes (acute rejection, pneumonia, graft failure, and death) was significantly greater in the prolonged recovery group (hazard ratio 2.604, 95% confidence interval 1.102–6.150, p = 0.029) compared with the rapid recovery group. Decreased donor terminal eGFR is a risk factor for prolonged recovery from DGF after deceased kidney transplantation. Prolonged DGF recovery time is associated with reduced graft function at 1-year post-transplant, and poor transplant outcome.
urology & nephrology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the impact of an extended recovery period on death - donor kidney transplant recipients after delayed graft function (DGF), and to explore the risk factors for an extended recovery period. Specifically, the authors used a new definition to measure the DGF recovery time, that is, the time from transplantation to achieving a stable estimated glomerular filtration rate (eGFR). The main objectives of the study are: 1. **Evaluate the impact of an extended recovery period on transplantation outcomes after DGF**: By analyzing whether an extended recovery period is associated with lower 1 - year transplantation function and poorer transplantation outcomes (such as acute rejection, pneumonia, graft failure, and death). 2. **Explore the risk factors for an extended recovery period**: Identify which factors may lead to an extended recovery period after DGF. ### Research Background - **Delayed Graft Function (DGF)**: DGF is an early complication after kidney transplantation, usually defined as the need for dialysis within one week after transplantation. - **DGF Recovery Time**: The traditional definition of DGF duration is the time of need for dialysis after transplantation (TND), but this method may not be sensitive enough. This paper proposes a new definition, that is, the time from transplantation to achieving a stable eGFR. - **Research Objectives**: Through the new definition of DGF recovery time, evaluate the impact of an extended recovery period on transplantation outcomes and explore its risk factors. ### Methods - **Study Population**: A retrospective analysis was performed on the data of 91 death - donor kidney transplant recipients between 2007 and 2016. - **DGF Recovery Time Definition**: The time from transplantation to achieving a stable eGFR. - **Grouping**: According to the median DGF recovery time (27 days), patients were divided into an extended recovery group (≥27 days) and a rapid recovery group (<27 days). ### Results - **Main Findings**: - The donor end - stage eGFR in the extended recovery group was significantly lower than that in the rapid recovery group (median 24.9 vs. 65.4 ml/min/1.73m², p = 0.004). - The eGFR in the extended recovery group at 1 year after transplantation was significantly lower than that in the rapid recovery group (50.6 ± 20.0 vs. 63.5 ± 21.4 ml/min/1.73m², p = 0.005). - The risk of adverse outcomes (acute rejection, pneumonia, graft failure, and death) in the extended recovery group was significantly higher than that in the rapid recovery group (hazard ratio 2.604, 95% confidence interval 1.102–6.150, p = 0.029). ### Conclusions - **A decrease in donor end - stage eGFR is an important risk factor for an extended DGF recovery after death - donor kidney transplantation**. - **An extended DGF recovery time is associated with a decline in transplantation function at 1 year after transplantation and poorer transplantation outcomes**. ### Discussion - **New Definition of DGF Recovery Time**: The traditional TND definition may not be sensitive enough, and the new definition proposed in this paper may be more suitable for evaluating the prognosis of DGF. - **Impact of Donor End - stage eGFR**: A higher donor end - stage eGFR increases the risk of an extended DGF recovery. - **Immunosuppressant Concentration**: The concentration of calcineurin inhibitors (CNIs) in the extended recovery group was lower than that in the rapid recovery group within 1 - 2 weeks after transplantation, but it is still unclear whether a low - dose CNIs can accelerate DGF recovery or improve long - term transplantation function. ### Significance - **Clinical Significance**: An extended DGF recovery is associated with poorer transplantation outcomes, suggesting that clinically, attention should be paid to the DGF recovery time, especially for patients with a lower donor end - stage eGFR. - **Future Research Directions**: Further explore the mechanism of an extended DGF recovery and how to shorten the DGF recovery time by optimizing treatment strategies.